Lutetium-177 PSMA radioligand therapy shows promise in metastatic castration-resistant prostate cancer
Radioligand therapy, using targeted prostate-specific membrane antigen (PSMA) compounds, is emerging as a promising treatment…
Browsing: Radiation Oncology & Nuclear Medicine
Targeted immunotherapy could boost radiotherapy response
Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with immunotherapy, a…
Common antiseptic could be cheap and easy way to improve cancer radiotherapy around the world
A simple injection of a common antiseptic could boost the cancer-killing effect of radiotherapy for…
Study uncovers inhibitory role of ‘Ter cells’ in cancer therapies
Targeted radiation is often used to study and treat diverse cancer types. A multidisciplinary research…
Photosynthetic bacteria-based cancer optotheranostics
Cancer is one of the most thought-provoking healthcare problems throughout the world. The development of…
Genomic test helps estimate risk of prostate cancer metastasis, death
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate…
Combination therapy with radiation shows promise in treating glioblastoma
In a study of mice, researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, have…
Technology allows doctors to see beam field during radiation treatment
Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC), USA, is the first cancer centre in the world…
Study finds shorter radiation regimen safe, effective for men with advanced prostate cancer
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, found shortening…
Providing inclusive care for LGBTQ2SPIA cancer patients
In an issue of the Journal of Medical Imaging and Radiation Sciences undergraduate researchers from the…